78 jobs for “Biotech Research Scientist”
EMBL-EBI Saffron Walden £3,452 pm
Develops the user-facing Europe PMC service, building fast, accessible interfaces for searching and navigating a corpus of over 47 million biomedical publications. Works with UX, product, back-end and data science colleagues to create reusable components, integrate REST APIs and JSON data, and improve performance, accessibility and maintainability within an Agile team.
Isomorphic Labs Cambridge, United States
Lead DMPK strategy across drug discovery projects, designing screening cascades and mechanistic experiments while integrating DMPK, PD and toxicology data for dose and safety predictions. Work closely with AI/ML platform teams to optimise computational ADME models and author regulatory sections, in a hybrid Cambridge, MA role.
Isomorphic Labs London
Lead formulation strategy for small molecules across drug discovery and preclinical development, designing technologies such as solid dispersions and co-crystals to improve solubility, stability and manufacturability. Work within an interdisciplinary team alongside AI/ML drug design platform groups, managing external CRO resources and authoring regulatory submissions.
EMBL-EBI Saffron Walden £3,452 pm
Maintains microbial genomes in Ensembl, loading new annotations, coordinating releases and diagnosing data issues. Develops functional annotation and pangenome pipelines, evaluates taxon-specific annotation tools, and builds Nextflow or Snakemake workflows with Python, relational databases and HPC or cloud infrastructure.
GSK London US$340,500 – US$567,500 pa
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability and chairing a cross-functional matrix Medicine Development Team spanning clinical, translational, regulatory, manufacturing and commercial. Drives strategy, go/no-go decisions and lifecycle plans for novel vaccine platforms such as mRNA and neoantigen-based therapies.
GSK Waltham, United States US$340,500 – US$567,500 pa
Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and represents the asset to senior governance boards.
Vertex Pharmaceuticals London
Leads the development and execution of international regulatory strategy across European and Rest of World markets, from first-in-human through post-marketing. Represents Global Regulatory Affairs on core development teams, manages project plans and resources, and advises senior management. Also a people manager within the International GRA leadership team, driving process improvement and regulatory policy engagement.
Pfizer Cambridge, United States US$176,600 – US$294,300 pa
Leads global evidence generation and health economics and outcomes research for a rare disease therapy, designing HEOR studies, economic models and value dossiers to support reimbursement and patient access. Works within a cross-functional matrix team and with country teams, guiding clinical trial design and payer-facing evidence strategy.
Pfizer Collegeville, United States US$176,600 – US$294,300 pa
Leads the global evidence generation strategy for a rare disease therapy, overseeing HEOR studies such as network meta-analyses, economic models, and non-interventional research from concept to publication. Partners with cross-functional teams and country affiliates to develop value dossiers and patient-reported outcome strategies that support reimbursement and market access. The role sits within Pfizer's HV&E team and involves managing external research collaborations and vendor relationships.
Nuclera Cambridge
Full-stack engineer building customer-facing cloud and instrument software plus internal tools supporting in-house protein screening services. Owns features end to end, from gathering requirements with biologists and stakeholders through technical design, implementation and testing across backend, frontend, dev-ops and QA.
Genomics London
Drive innovation as a strategic consultant on high-impact drug discovery projects with external pharma and biotech partners. Navigate the full development pipeline from target discovery to patient stratification, applying statistical human genetics and large-scale genomic data analysis in R or Python. Partner-facing role translating complex findings into actionable insights.
CSL Maidenhead
Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.
CSL Opfikon, Switzerland
Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence, and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.
Recursion Salt Lake City, United States US$200,000 – US$220,500 pa
Lead a team of computational biologists in early discovery, acting as a player-coach who balances hands-on analysis with mentorship. Integrate phenomics, transcriptomics, genomics and proteomics data to nominate oncology and immunology targets, define validation criteria and precision medicine strategies, partnering with biologists, engineers and translational experts.
Recursion New York, United States US$151,800 – US$220,660 pa
Integrate phenomics, transcriptomics, genomics and proteomics data to nominate novel targets and validate immunology and inflammation disease biology, piloting new methods for target discovery and early patient population hypotheses. Partner cross-functionally with biologists, chemists, data scientists and engineers to build data packages that drive program milestones and investment decisions.
